Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1835555288;55289;55290 chr2:178602339;178602338;178602337chr2:179467066;179467065;179467064
N2AB1671450365;50366;50367 chr2:178602339;178602338;178602337chr2:179467066;179467065;179467064
N2A1578747584;47585;47586 chr2:178602339;178602338;178602337chr2:179467066;179467065;179467064
N2B929028093;28094;28095 chr2:178602339;178602338;178602337chr2:179467066;179467065;179467064
Novex-1941528468;28469;28470 chr2:178602339;178602338;178602337chr2:179467066;179467065;179467064
Novex-2948228669;28670;28671 chr2:178602339;178602338;178602337chr2:179467066;179467065;179467064
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Fn3-21
  • Domain position: 84
  • Structural Position: 114
  • Q(SASA): 0.4527
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/P rs2053671258 None 0.998 D 0.535 0.415 0.423002944196 gnomAD-3.1.2 6.58E-06 None None None None I None 0 0 0 0 0 None 0 0 1.47E-05 0 0
A/P rs2053671258 None 0.998 D 0.535 0.415 0.423002944196 gnomAD-4.0.0 5.07543E-06 None None None None I None 0 0 None 0 0 None 0 0 6.02503E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.4453 ambiguous 0.5038 ambiguous -0.751 Destabilizing 1.0 D 0.445 neutral None None None None I
A/D 0.542 ambiguous 0.458 ambiguous -0.586 Destabilizing 0.998 D 0.699 prob.neutral N 0.502412734 None None I
A/E 0.3833 ambiguous 0.332 benign -0.75 Destabilizing 0.999 D 0.501 neutral None None None None I
A/F 0.3165 likely_benign 0.3416 ambiguous -0.919 Destabilizing 0.996 D 0.708 prob.delet. None None None None I
A/G 0.1979 likely_benign 0.1889 benign -0.284 Destabilizing 0.993 D 0.377 neutral N 0.480078517 None None I
A/H 0.5947 likely_pathogenic 0.5689 pathogenic -0.278 Destabilizing 1.0 D 0.709 prob.delet. None None None None I
A/I 0.1945 likely_benign 0.2073 benign -0.371 Destabilizing 0.304 N 0.285 neutral None None None None I
A/K 0.5538 ambiguous 0.4854 ambiguous -0.6 Destabilizing 0.999 D 0.501 neutral None None None None I
A/L 0.2511 likely_benign 0.2516 benign -0.371 Destabilizing 0.871 D 0.482 neutral None None None None I
A/M 0.2413 likely_benign 0.2505 benign -0.4 Destabilizing 0.996 D 0.533 neutral None None None None I
A/N 0.4148 ambiguous 0.3769 ambiguous -0.265 Destabilizing 0.999 D 0.699 prob.neutral None None None None I
A/P 0.8227 likely_pathogenic 0.7808 pathogenic -0.3 Destabilizing 0.998 D 0.535 neutral D 0.530685207 None None I
A/Q 0.4549 ambiguous 0.4212 ambiguous -0.583 Destabilizing 0.999 D 0.531 neutral None None None None I
A/R 0.4923 ambiguous 0.4519 ambiguous -0.087 Destabilizing 0.999 D 0.529 neutral None None None None I
A/S 0.1449 likely_benign 0.1408 benign -0.441 Destabilizing 0.98 D 0.429 neutral N 0.476675157 None None I
A/T 0.1532 likely_benign 0.1481 benign -0.532 Destabilizing 0.961 D 0.383 neutral N 0.491816897 None None I
A/V 0.097 likely_benign 0.1028 benign -0.3 Destabilizing 0.248 N 0.207 neutral N 0.495892731 None None I
A/W 0.7658 likely_pathogenic 0.7773 pathogenic -1.031 Destabilizing 1.0 D 0.766 deleterious None None None None I
A/Y 0.5029 ambiguous 0.5039 ambiguous -0.691 Destabilizing 0.999 D 0.699 prob.neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.